Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202,024 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer: A Multicenter Randomized Phase 3 Clinical Trial.
Ji Y, Du X, Zhu W, Yang Y, Ma J, Zhang L, Li J, Tao H, Xia J, Yang H, Huang J, Bao Y, Du D, Liu D, Wang X, Li C, Yang X, Zeng M, Liu Z, Zheng W, Pu J, Chen J, Hu W, Li P, Wang J, Xu Y, Zheng X, Chen J, Wang W, Tao G, Cai J, Zhao J, Zhu J, Jiang M, Yan Y, Xu G, Bu S, Song B, Xie K, Huang S, Zheng Y, Sheng L, Lai X, Chen Y, Cheng L, Hu X, Ji W, Fang M, Kong Y, Yu X, Li H, Li R, Shi L, Shen W, Zhu C, Lv J, Huang R, He H, Chen M. Ji Y, et al. Among authors: wang x, wang w, wang j. JAMA Oncol. 2021 Oct 1;7(10):1459-1466. doi: 10.1001/jamaoncol.2021.2705. JAMA Oncol. 2021. PMID: 34351356 Free PMC article. Clinical Trial.
Five-year survival rate analysis: the combination of fortnightly-administration of endostar and concurrent chemoradiotherapy versus concurrent chemoradiotherapy in the treatment of inoperable locally advanced non-small cell lung cancer.
Ma H, Peng F, Xu Y, Bao Y, Hu X, Wang J, Fang M, Kong Y, Dong B, Chen M. Ma H, et al. Among authors: wang j. Ann Palliat Med. 2021 Jul;10(7):7560-7570. doi: 10.21037/apm-21-1092. Ann Palliat Med. 2021. PMID: 34353044 Free article.
The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience.
Xu Y, Wang Z, Liu G, Zheng X, Wang Y, Feng W, Lai X, Zhou X, Li P, Ma H, Wang J, Hu X, Chen M. Xu Y, et al. Among authors: wang z, wang j, wang y. J Cancer Res Ther. 2016 Oct;12(Supplement):82-88. doi: 10.4103/0973-1482.191640. J Cancer Res Ther. 2016. PMID: 27721262 Free article.
202,024 results
You have reached the last available page of results. Please see the User Guide for more information.